AI brief of an SEC Form 8-K · Lantheus (LNTH)

Lantheus Q2 revenue falls 4.1% to $378.0 million; cuts 2025 adjusted EPS guidance

Negative Impact 4 of 5 earnings Written later

Lantheus reported second-quarter 2025 revenue of $378.0 million, down 4.1%, and adjusted diluted EPS of $1.57, down 12.8%, while GAAP diluted EPS rose 27.3% to $1.12. The company cut its full-year 2025 revenue and adjusted EPS guidance and said it faced increased competition in PSMA PET imaging, which hurt PYLARIFY sales; it also authorized a new $400 million share repurchase program.

Key points

  • Q2 2025 worldwide revenue was $378.0 million, down from $394.1 million; PYLARIFY sales fell 8.3% to $250.6 million.
  • Adjusted diluted EPS was $1.57, down from $1.80; GAAP diluted EPS was $1.12, up from $0.88.
  • FY 2025 revenue guidance was lowered to $1.475 billion-$1.51 billion from $1.550 billion-$1.585 billion; adjusted EPS guidance was lowered to $5.50-$5.70 from $6.60-$6.70.
  • The Board authorized repurchases of up to $400 million of common stock through December 31, 2027, replacing the program announced in November 2024.

The filing

CompanyLantheus (LNTH)
Form8-K, current report
Filed with the SECAug 6, 2025, 7:39 AM ET
Accession number0000950170-25-103543

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 12:57 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 06, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.